Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study

被引:9
|
作者
Crous-Bou, Marta [1 ,2 ,3 ]
Porta, Miquel [1 ,2 ,3 ]
Morales, Eva [1 ]
Lopez, Tomas [1 ,3 ]
Carrato, Alfredo [4 ]
Puigdomenech, Elisa [1 ,2 ,3 ]
Real, Francisco X. [1 ,5 ,6 ]
机构
[1] Univ Autonoma Barcelona, Clin & Mol Epidemiol Canc Unit, IMIM, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Fac Med, Barcelona 08003, Spain
[3] CIBERESP, Barcelona, Spain
[4] Univ Miguel Hernandez, Hosp Univ Elche, Alacant, Spain
[5] Ctr Nacl Invest Oncol, Madrid, Spain
[6] Univ Pompeu Fabra, Barcelona, Spain
关键词
Medical conditions; Diabetes mellitus; Pancreatitis; Peptic ulcer; Pancreatic ductal adenocarcinoma; Pancreatic neoplasms; Etiology; K-ras oncogene; RISK-FACTORS; LIFE-STYLE; CODON; 12; CANCER; HISTORY; INFLAMMATION; ASSOCIATION; P53; EPIDEMIOLOGY; METAANALYSIS;
D O I
10.1007/s10552-008-9267-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In pancreatic ductal adenocarcinoma (PDA) evidence on the etiopathogenic role of past medical conditions in the occurrence and persistence of K-ras mutations is scant. Incident cases of PDA were interviewed face-to-face about past medical history and other factors. Logistic regression was used to compare PDA cases (n = 120) with wild-type and mutated K-ras tumors (case-case study). Patients with wild-type K-ras tumors were more likely to have a prior diagnosis of pancreatitis (Odds ratio [OR] = 6.11, p = 0.041). Diabetes mellitus (DM) was non-significantly more common among cases with a K-ras wild-type tumor, and the OR for DM of > 6 years of duration was 4.54 (p = 0.39). Patients with wild-type K-ras were significantly more likely to have had a surgically treated peptic ulcer (OR = 9.03, p = 0.027). The probability of having a K-ras wild-type tumor increased with the number of medical conditions (p for trend = 0.012); the corresponding OR for two or more medical conditions was 4.46 (95% CI: 1.37-14.50). Results raise the hypothesis that pancreatitis and possibly peptic ulcer might influence pancreatic carcinogenesis through pathways independent of K-ras mutation, perhaps related to growth factors or mediators of the inflammatory response. Large unselected studies should be conducted to refute or replicate our findings.
引用
收藏
页码:591 / 599
页数:9
相关论文
共 50 条
  • [41] K-RAS MUTATION AND PANCREATIC ADENOCARCINOMA - STATE-OF-THE-ART
    CALDAS, C
    KERN, SE
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1995, 18 (01) : 1 - 6
  • [42] ANALYSIS OF K-RAS MUTATIONS IN CHRONIC-PANCREATITIS WITH DUCTAL HYPERPLASIA
    RIVERA, JA
    FERNANDEZDELCASTILLO, C
    RALL, CJN
    GRAEMECOOK, F
    WARSHAW, AL
    RUSTGI, AK
    GASTROENTEROLOGY, 1995, 108 (04) : A386 - A386
  • [43] PANCREATIC AND PERIPANCREATIC NEOPLASMS - CORRELATION OF MORPHOLOGY WITH K-RAS MUTATIONS
    RUEBNER, BH
    KRAGEL, S
    MADEWELL, B
    MIN, BH
    GUMERLOCK, P
    FASEB JOURNAL, 1993, 7 (03): : A28 - A28
  • [44] K-ras mutations as pathogenetic and diagnostic markers in pancreatic cancer
    Mannhalter C.
    Koizar D.
    Chott A.
    Mitterbauer G.
    Udvardi G.
    Acta chirurgica Austriaca, 1998, 30 (3) : 196 - 197
  • [45] K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma
    Wilentz, RE
    Chung, CH
    Sturm, PDJ
    Musler, A
    Sohn, TA
    Offerhaus, GJA
    Yeo, CJ
    Hruban, RH
    Slebos, RJC
    CANCER, 1998, 82 (01) : 96 - 103
  • [46] K-Ras and CDKN2a Mutations in Pancreatic Cancer
    Rachakonda, S.
    Bauer, A.
    Canzian, F.
    Scarpa, A.
    Neoptolemos, J.
    Werner, J.
    Giese, N.
    Heller, A.
    Hoheisel, J.
    Kumar, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S166 - S166
  • [47] BRAF and K-ras gene mutations in human pancreatic cancers
    Ishimura, N
    Yamasawa, K
    Rumi, MAK
    Kadowaki, Y
    Ishihara, S
    Amano, Y
    Nio, Y
    Higami, T
    Kinoshita, Y
    CANCER LETTERS, 2003, 199 (02) : 169 - 173
  • [48] Occupational exposures and K-ras mutations in exocrine pancreatic cancer
    Porta, M
    Alguacil, J
    Malats, N
    Kauppinen, T
    Kogevinas, M
    Benavides, F
    Partanen, T
    Carrato, A
    Rifa, J
    Guarner, L
    EPIDEMIOLOGY, 2000, 11 (04) : S93 - S93
  • [49] Detection of K-ras point mutation increases the efficacy of EUS-FNA for the diagnosis of ductal pancreatic adenocarcinoma
    Maluf, F
    Kubrusly, MS
    da Cunha, JEM
    Sakai, P
    Jukemura, J
    Montagnini, A
    GASTROINTESTINAL ENDOSCOPY, 2004, 59 (05) : AB223 - AB223
  • [50] Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma
    Jeong, Seok
    Lee, Don Haeng
    Lee, Jung Il
    Lee, Jin-Woo
    Kwon, Kye Sook
    Kim, Pum-Soo
    Kim, Hyung Gil
    Shin, Yong Woon
    Kim, Young Soo
    Kim, Young Bae
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (43) : 6765 - 6769